Product Information
MIDODRINE HCL 5 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1113 per EA under NDC 68382073801. Its NADAC has been published 293 times since Feb 24, 2021.
FDA first approved this application on Sep 1, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382073801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MIDODRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213055FDA Approved
9/1/2020
TE Code
AB
On Market Since
9/17/2020
Pharmacological Classes
Price Statistics
The NADAC for MIDODRINE HCL 5 MG TABLET has been published 293 times since Feb 24, 2021, and over the history we have for it it has declined 67.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1113 per EA |
|---|---|
| All-time high | $0.3736 (Apr 14, 2021) |
| All-time low | $0.1084 (Feb 18, 2026) |
| 52-week high | $0.1148 |
| 52-week low | $0.1084 |
| Median price | $0.1757 |
| Average price | $0.1984 |
| Largest weekly change | +38.5% (Aug 21, 2024) |
| Weeks tracked | 293 |
| Tracking since | Feb 24, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Midodrine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Midodrine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIDODRINE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MIDODRINE HCL 5 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1113 per EA (NDC 68382073801), effective Sep 30, 2026.
How has the price of MIDODRINE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MIDODRINE HCL 5 MG TABLET has declined 67.6%. It has been tracked across 293 weekly CMS publications since Feb 24, 2021.
What are the highest and lowest recorded NADAC prices for MIDODRINE HCL 5 MG TABLET?
Since Feb 24, 2021, the NADAC for MIDODRINE HCL 5 MG TABLET has ranged from a low of $0.1084 (Feb 18, 2026) to a high of $0.3736 (Apr 14, 2021), with a median of $0.1757 per EA.
Are there cheaper alternatives to MIDODRINE HCL 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MIDODRINE HCL 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MIDODRINE HCL 5 MG TABLET?
MIDODRINE HCL 5 MG TABLET (NDC 68382073801) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.